The main cytokine induced by the interaction of oral epithelial cells with C. glabrata is granulocyte monocyte colony-stimulating factor (GM-CSF); however, the mechanisms regulating this response are unknown. Based on previously published information on the interactions of C. albicans with oral epithelial cells, we hypothesized that interaction with viable C. glabrata triggers GM-CSF synthesis via NF-κB activation. We found that C. glabrata-induced GM-CSF synthesis was adhesion-dependent, enhanced by endocytosis, and required fungal viability. NF-κB activation was noted during interaction of epithelial cells with C. glabrata, and pre-treatment with an NF-κB inhibitor partly inhibited GM-CSF synthesis. Blocking TLR4 with anti-TLR4 antibody did not inhibit GM-CSF production. In contrast, an anti-CDw17 antibody triggered significant inhibition of NF-κB activation and GM-CSF synthesis. β-glucans did not stimulate GM-CSF synthesis, suggesting that the CDw17/NF-κB/GM-CSF pathway may be β-glucan-independent. This study provides new insights into the mechanism of GM-CSF induction by C. glabrata.
Get full access to this article
View all access options for this article.
References
1.
Asai Y, Ohyama Y, Gen K, Ogawa T -2001-. Bacterial fimbriae and their peptides activate human gingival epithelial cells through Toll-like receptor 2. Infect Immun69:7387–7395.
2.
Baker N, Hansson GC, Leffler H, Riise G, Svanborg-Edén C -1990-. Glycosphingolipid receptors for Pseudomonas aeruginosa. Infect Immun58:2361–2366.
3.
Cormack BP, Ghori N, Falkow S -1999-. An adhesin of the yeast pathogen Candida glabrata mediating adherence to human epithelial cells. Science285:578–582.
4.
Davies AN, Brailsford S, Broadley K, Beighton D -2002-. Oral yeast carriage in patients with advanced cancer. Oral Microbiol Immunol17:79–84.
5.
deGroot PW, Kraneveld EA, Yin QY, Dekker HL, Gross U, Crielaard W, et al. -2008-. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins. Eukaryot Cell7:1951–1964.
6.
Dickson MA, Hahn WC, Ino Y, Ronfard V, Wu JY, Weinberg RA, et al. -2000-. Human keratinocytes that express hTERT and also bypass a p16 INK4a- enforced mechanism that limits life span become immortal yet retain normal growth and differentiation characteristics. Mol Cell Biol20: 1436–1447.
7.
Dongari-Bagtzoglou A, Kashleva H -2003-. Candida albicans triggers interleukin-8 secretion by oral epithelial cells. Microb Pathog34:169–177.
8.
Dongari-Bagtzoglou A, Villar CC, Kashleva H -2005-. Candida albicans-infected oral epithelial cells augment the anti-fungal activity of human neutrophils in vitro. Med Mycol43:545–549.
Eversole LR, Reichart PA, Ficarra G, Schmidt-Westhausen A, Romagnoli P, Pimpinelli N -1997-. Oral keratinocyte immune responses in HIV-associated candidiasis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod84:372–380.
11.
Fantini J, Garmy N, Yahi N -2006-. Prediction of glycolipid-binding domains from the amino acid sequence of lipid raft-associated proteins: application to HpaA, a protein involved in the adhesion of Helicobacter pylori to gastrointestinal cells. Biochemistry45:10957–10962.
12.
Fidel PL Jr, Vazquez JA, Sobel JD -1999-. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans. Clin Microbiol12:80–96.
13.
Hahn PY, Evans SE, Kottom TJ, Standing JE, Pagano RE, Limper AH -2003-. Pneumocystis carinii cell wall beta-glucan induces release of macrophage inflammatory protein-2 from alveolar epithelial cells via a lactosylceramide-mediated mechanism. J Biol Chem278:2043–2050.
14.
Iwabuchi K, Nagaoka I -2002-. Lactosylceramide-enriched glycosphingo-lipid signaling domain mediates superoxide generation from human neutrophils. Blood100:1454–1464.
15.
Jimenez-Lucho V, Ginsburg V, Krivan HC -1990-. Cryptococcus neoformans, Candida albicans, and other fungi bind specifically to the glycosphingolipid lactosylceramide -Gal beta 1-4Glc beta 1-1Cer-, a possible adhesion receptor for yeasts. Infect Immun58:2085–2090.
16.
Kadir T, Pisiriciler R, Akyuz S, Yarat A, Emekli N, Ipbuker A -2002-. Mycological and cytological examination of oral candidal carriage in diabetic patients and non-diabetic control subjects: thorough analysis of local aetiologic and systemic factors. J Oral Rehabil29:452–457.
17.
Krivan HC, Olson LD, Barile MF, Ginsburg V, Roberts DD -1989-. Adhesion of Mycoplasma pneumoniae to sulfated glycolipids and inhibition by dextran sulfate. J Biol Chem264:9283–9288.
18.
Kusumoto Y, Hirano H, Saitoh K, Yamada S, Takedachi M, Nozaki T, et al. -2004-. Human gingival epithelial cells produce chemotactic factors interleukin-8 and monocyte chemoattractant protein-1 after stimulation with Porphyromonas gingivalis via Toll-like receptor 2. J Periodontol75:370–379.
19.
Li L, Dongari-Bagtzoglou A -2007-. Oral epithelium-Candida glabrata interactions in vitro. Oral Microbiol Immunol22:182–187.
20.
Li L, Kashleva H, Dongari-Bagtzoglou A -2007-. Cytotoxic and cytokine-inducing properties of Candida glabrata in single and mixed oral infection models. Microb Pathog42:138–147.
21.
Markwell MA, Svennerholm L, Paulson JC -1981-. Specific gangliosides function as host cell receptors for Sendai virus. Proc Natl Acad Sci USA78:5406–5410.
22.
Masia Canuto M, Gutierrez Rodero F, Ortiz de la Tabla Ducasse V, Hernandez Aguado I, Martin Gonzalez C, Sanchez Sevillano A, et al. -2000-. Determinants for the development of oropharyngeal colonization or infection by fluconazole-resistant Candida strains in HIV-infected patients. Eur J Clin Microbiol Infect Dis19:593–601.
23.
Murciano C, Villamon E, Gozalbo D, Roig P, O’Connor JE, Gil ML -2006-. Toll-like receptor 4 defective mice carrying point or null mutations do not show increased susceptibility to Candida albicans in a model of hematogenously disseminated infection. Med Mycol44: 149–157.
24.
Muzyka BC -2005-. Oral fungal infections. Dent Clin North Am49:49–65.
25.
Neal MD, Leaphart C, Levy R, Prince J, Billiar T, Watkins S, et al. -2006-. Enterocyte TLR4 mediates phagocytosis and translocation of bacteria across the intestinal barrier. J Immunol176:3070–3079.
26.
Netea MG, van der Meer JW, Kullberg BJ -2006-. Both TLR2 and TLR4 are involved in the recognition of Candida albicans. Reply to “TLR2, but not TLR4, triggers cytokine production by murine cells in response to Candida albicans yeasts and hyphae” by Gil and Gozalbo -Microbes Infect 8:2821–2822-. Microbes Infect8:2823–2824.
27.
Nicolatou-Galitis O, Dardoufas K, Markoulatos P, Sotiropoulou-Lontou A, Kyprianou K, Kolitsi G, et al. -2001-. Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor -GM-CSF- mouthwash. J Oral Pathol Med30:471–480.
28.
Pivarcsi A, Bodai L, Réthi B, Kenderessy-Szabó A, Koreck A, Széll M, et al. -2003-. Expression and function of Toll-like receptors 2 and 4 in human keratinocytes. Int Immunol15:721–730.
29.
Van der Graaf CA, Netea MG, Verschueren I, van der Meer JW, Kullberg BJ -2005-. Differential cytokine production and Toll-like receptor signaling pathways by Candida albicans blastoconidia and hyphae. Infect Immun73:7458–7464.
30.
Villamón E, Gozalbo D, Roig P, O’Connor JE, Fradelizi D, Gil ML -2004-. Toll-like receptor 2 is essential in murine defenses against Candida albicans infections. Microbes Infect6:1–7.
31.
Villar CC, Kashleva H, Nobile CJ, Mitchell AP, Dongari-Bagtzoglou A -2007-. Mucosal tissue invasion by Candida albicans is associated with E-cadherin degradation, mediated by transcription factor Rim101p and protease Sap5p. Infect Immun75:2126–2135.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
